Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus R Meyer

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Analytical and Bioanalytical Chemistry|August 18, 2014
Trends in analyzing emerging drugs of abuse--from seized samples to body samplesMarkus R Meyer
Archives of Toxicology|September 26, 2016
New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokineticsMarkus R Meyer
Handbook of Experimental Pharmacology|February 25, 2018
Toxicokinetics of NPS: Update 2017Markus R Meyer
The Science of the Total Environment|July 2, 2014
Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometryMarie Mardal, Markus R Meyer
Drug Testing and Analysis|June 15, 2011
In vitro approaches to studying the metabolism of new psychoactive compoundsFrank T Peters, Markus R Meyer
Chemical Research in Toxicology|May 26, 2009
Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylationMarkus R Meyer, Hans H Maurer
Therapeutic Drug Monitoring|August 20, 2019
Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive SubstancesSascha K Manier, Markus R Meyer
Analytica Chimica Acta|May 31, 2016
Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?Markus R Meyer, Hans H Maurer
Pharmacogenomics|February 22, 2011
Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuseMarkus R Meyer, Hans H Maurer
Current Drug Metabolism|June 15, 2010
Metabolism of designer drugs of abuse: an updated reviewMarkus R Meyer, Hans H Maurer
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Analytical and Bioanalytical Chemistry|August 18, 2014
Trends in analyzing emerging drugs of abuse--from seized samples to body samplesMarkus R Meyer
Archives of Toxicology|September 26, 2016
New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokineticsMarkus R Meyer
Handbook of Experimental Pharmacology|February 25, 2018
Toxicokinetics of NPS: Update 2017Markus R Meyer
The Science of the Total Environment|July 2, 2014
Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometryMarie Mardal, Markus R Meyer
Drug Testing and Analysis|June 15, 2011
In vitro approaches to studying the metabolism of new psychoactive compoundsFrank T Peters, Markus R Meyer
Chemical Research in Toxicology|May 26, 2009
Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylationMarkus R Meyer, Hans H Maurer
Therapeutic Drug Monitoring|August 20, 2019
Current Situation of the Metabolomics Techniques Used for the Metabolism Studies of New Psychoactive SubstancesSascha K Manier, Markus R Meyer
Analytica Chimica Acta|May 31, 2016
Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?Markus R Meyer, Hans H Maurer
Pharmacogenomics|February 22, 2011
Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuseMarkus R Meyer, Hans H Maurer
Current Drug Metabolism|June 15, 2010
Metabolism of designer drugs of abuse: an updated reviewMarkus R Meyer, Hans H Maurer
Pageof 27